Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
NCT06381830Phase 2Terminated
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2024
- Primary completion
- Apr 2026
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ISIKOK-19 in B-cell non-Hodgkin lymphoma, sponsored by First Affiliated Hospital of Soochow University. Started Jan 2024; status: terminated.
02
Drugs
ISIKOK-19
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT06381830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381830.